Compare AKR Corporindo Tbk (AKRA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AKR Corporindo Tbk vs UBC Medical Indonesia Tbk. — how do they compare? AKR Corporindo Tbk trades at Rp1,400 (market cap 28T, 6.58M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: AKR Corporindo Tbk is far larger — about 44× UBC Medical Indonesia Tbk.'s market cap, and AKR Corporindo Tbk is more actively traded (6.58M versus 843K). Which is the better fit depends on your goals.
| AKRA | LABS | |
|---|---|---|
Market Cap | 28T | 635.95B |
Volume | 6.58M | 843K |
Lot | 65.84K | 8.43K |
Turnover | 9.25B | 137.6M |
Average Price | 1,405.14 | 163.22 |
Value | 9.25B | 137.6M |
Indicative Equilibrium Price | 1,400 | 165 |
Indicative Equilibrium Volume | 1.94K | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AKR Corporindo Tbk
PT AKR Corporindo Tbk was established in Surabaya on November 28, 1977 based on the Notarial Deed No. 46 of Sastra Kosasih, S.H., which was amended by Notarial Deed No. 26 of the same notary dated April 12, 1978 . In 2004, the Company changed its name from PT Aneka Kimia Raya Tbk to PT AKR Corporindo Tbk. PT Aneka Kimia Raya is the largest chemical distributor in Indonesia. The Company is dominantly positioned within the industry, distributing more than 40 chemical products. The Company is foreign investment.
Read more on AKRA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
